Clinical Trial Update: Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating ways to overcome primary resistance to immunotherapy in metastatic melanoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Dr. Ronnie Shapira | Conditions: Malignant Melanoma, Metastatic Melanoma | Phase 2 | Status: COMPLETED